Hospital
Ector County Hospital District
Ector County Hospital District was paid $14.57M by Medicaid between Jan 2018 and Dec 2024, across 160 billing codes. Its largest line is 99284, emergency room visit (serious) — 24% of everything it billed.
33Billing provider infoECTOR COUNTY HOSPITAL DISTRICT
ODESSA, TX 79761
ODESSA, TX 79761
33aNPI1740273994assigned 08/23/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$14.57M
24GClaims381,133
24DCodes billed160
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Texas
Rank by total paid#10 of 109
Median peer was paid$1.15M
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 389 | $23K | |
| 2019 | 394 | $12K | |
| 2020 | 5,493 | $214K | |
| 2021 | 94,982 | $3.18M | |
| 2022 | 110,166 | $4.26M | |
| 2023 | 112,436 | $4.69M | |
| 2024incomplete | 57,273 | $2.19M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 24% | 14,739 | 13,538 | $3.53M |
| 87631 | 12% | 10,795 | 10,190 | $1.79M | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.7% | 16,989 | 16,255 | $1.41M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.6% | 19,898 | 18,785 | $960K |
| 87428 | 6.4% | 16,556 | 16,011 | $930K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.5% | 11,070 | 10,548 | $803K |
| 41899 | Unlisted procedure, dentoalveolar structures | 4.4% | 683 | 598 | $638K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.1% | 18,628 | 17,926 | $458K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.0% | 4,820 | 4,649 | $433K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.9% | 7,834 | 7,458 | $421K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.7% | 3,429 | 3,280 | $398K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.6% | 20,746 | 10,022 | $383K |
148 more codes
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 2.3% | 160 | $342K |
| 99285 | Emergency room visit (most serious) | 1.8% | 2,025 | $256K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.6% | 5,554 | $239K |
| 80053 | Comprehensive metabolic panel | <1% | 20,765 | $119K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 2,388 | $114K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 20,959 | $110K |
| 87800 | <1% | 1,799 | $107K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,656 | $85K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,268 | $72K |
| 87807 | <1% | 4,587 | $67K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 7,479 | $65K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,630 | $55K |
| G0378 | Hospital observation service, per hour | <1% | 149 | $46K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,435 | $44K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,281 | $43K |
| 99218 | <1% | 206 | $42K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,519 | $41K |
| 84702 | <1% | 2,435 | $34K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 330 | $32K |
| 81001 | <1% | 11,442 | $31K | |
| 80061 | Lipid panel | <1% | 5,326 | $26K |
| 36415 | Collection of venous blood by venipuncture | <1% | 44,261 | $21K |
| 80047 | <1% | 3,135 | $21K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,635 | $21K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 718 | $18K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 361 | $18K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 578 | $18K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 53 | $18K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 106 | $17K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,739 | $16K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,769 | $14K |
| 80305 | <1% | 961 | $13K | |
| 0352U | <1% | 1,233 | $11K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 777 | $11K |
| 83690 | <1% | 2,889 | $11K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 124 | $10K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 176 | $10K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,801 | $10K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,259 | $9K |
| 86592 | <1% | 1,428 | $8K | |
| 85014 | <1% | 6,040 | $8K | |
| 86803 | <1% | 400 | $8K | |
| 82948 | <1% | 3,238 | $7K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 65 | $7K |
| 81514 | <1% | 48 | $7K | |
| 87340 | <1% | 499 | $7K | |
| 81003 | <1% | 1,976 | $6K | |
| 83880 | <1% | 1,591 | $6K | |
| 87070 | <1% | 654 | $6K | |
| 84484 | <1% | 2,215 | $5K | |
| 82950 | <1% | 1,410 | $5K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 3,560 | $5K |
| 86706 | <1% | 359 | $5K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 109 | $5K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 246 | $5K |
| 86762 | <1% | 209 | $4K | |
| 85027 | <1% | 2,052 | $4K | |
| 86900 | <1% | 1,422 | $4K | |
| 86901 | <1% | 1,421 | $4K | |
| 87081 | <1% | 424 | $4K | |
| 88300 | <1% | 475 | $3K | |
| 87420 | <1% | 186 | $3K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 164 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 286 | $3K |
| 85730 | <1% | 1,903 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,448 | $3K |
| 0353U | <1% | 732 | $3K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 258 | $2K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 24 | $2K |
| 85610 | <1% | 2,516 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 36 | $2K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 50 | $2K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 258 | $2K |
| 84439 | <1% | 588 | $2K | |
| 81025 | <1% | 249 | $2K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 915 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 54 | $1K |
| 87210 | <1% | 265 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 25 | $1K |
| 82105 | <1% | 57 | $1K | |
| 85018 | <1% | 331 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,876 | $954.24 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 823 | $936.22 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 25 | $841.81 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,845 | $828.12 |
| 84134 | <1% | 1,114 | $797.84 | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 14 | $788.75 |
| 87186 | <1% | 1,046 | $737.99 | |
| 73630 | <1% | 13 | $715.01 | |
| 82607 | <1% | 1,214 | $652.55 | |
| 83735 | <1% | 838 | $652.31 | |
| 80177 | <1% | 717 | $547.37 | |
| 87077 | <1% | 986 | $525.95 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 535 | $510.40 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 19 | $506.27 |
| 87480 | <1% | 16 | $501.98 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 22 | $463.92 |
| 84703 | <1% | 45 | $410.84 | |
| 83525 | <1% | 25 | $389.31 | |
| 80164 | <1% | 685 | $377.16 | |
| 86885 | <1% | 121 | $338.85 | |
| 72100 | <1% | 12 | $338.49 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 12 | $328.74 |
| 82746 | <1% | 861 | $319.25 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 259 | $310.45 |
| 87205 | <1% | 252 | $309.10 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,059 | $301.12 |
| 82077 | <1% | 16 | $294.26 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 283 | $234.93 |
| 83655 | <1% | 13 | $234.48 | |
| 84480 | <1% | 13 | $216.14 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 41 | $209.20 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 995 | $208.80 |
| 85007 | <1% | 285 | $205.29 | |
| 83605 | <1% | 60 | $167.18 | |
| 99152 | <1% | 49 | $165.57 | |
| 82570 | <1% | 338 | $121.80 | |
| 86003 | <1% | 16 | $112.88 | |
| 80171 | <1% | 15 | $103.12 | |
| 86140 | <1% | 197 | $95.98 | |
| 84436 | <1% | 98 | $87.34 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 199 | $84.55 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 98 | $69.70 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 136 | $63.39 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 381 | $36.87 |
| 82330 | <1% | 18 | $30.84 | |
| 84550 | <1% | 76 | $26.60 | |
| 84100 | <1% | 114 | $25.07 | |
| 87075 | <1% | 25 | $23.85 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 65 | $18.32 |
| 82043 | <1% | 121 | $14.58 | |
| A9150 | Non-prescription drugs | <1% | 13 | $13.93 |
| 81511 | <1% | 14 | $13.46 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 62 | $12.85 |
| 83615 | <1% | 22 | $10.14 | |
| 87102 | <1% | 12 | $7.06 | |
| A4217 | Sterile water/saline, 500 ml | <1% | 12 | $6.76 |
| 83540 | <1% | 56 | $5.43 | |
| 87206 | <1% | 13 | $4.53 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 25 | $2.30 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 19 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 13 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 14 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 0% | 13 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 370 | $0.00 |
| 93017 | 0% | 14 | $0.00 | |
| 77080 | 0% | 16 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTIPPIN, RUSSELL (PRESIDENT/CEO)